Article
Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis
OncoTargets and Therapy · 2020 · Cheng S, Zhang Z, Hu C, Xing N, Xia Y, Pang B
Key facts
| Title | Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis |
|---|---|
| First author | Cheng S, Zhang Z, Hu C, Xing N, Xia Y, Pang B |
| Journal | OncoTargets and Therapy |
| Published | Jul 7, 2020 |
| DOI | 10.2147/OTT.S257329 |
| Devices mentioned | 091526, K973350, K990827 |
| Product codes mentioned | JLX, KQP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1